Weibo Cai is a Vilas Distinguished Achievement Professor of Radiology, Medical Physics, Materials Science & Engineering, and Pharmaceutical Sciences at the University of Wisconsin - Madison. He received a BS degree in Chemistry from Nanjing University, China (1995) and a PhD degree in Chemistry from the University of California San Diego (2004). Between 2005 and 2008, Dr. Cai did his post-doctoral research in the Molecular Imaging Program at Stanford University. In February 2008, Dr. Cai joined the University of Wisconsin - Madison as a Biomedical Engineering Cluster Hire, and was promoted to Associate Professor with Tenure in 2014, and Full Professor in 2018. Dr. Cai’s research at UW-Madison is primarily focused on molecular imaging and nanobiotechnology.

Dr Laura Domigan is a biomaterials scientist based in the Department of Chemical and Materials Engineering at the University of Auckland Waipapa Taumata Rau. She is the co-founder and Chief Science Officer at Opo Bio Aotearoa, New Zealand’s first cultivated meat company. 

Laura’s research focus is sustainable protein materials, including formulating new biomaterials for surgical use and cell-based meat production.

Scientia Professor Justin Gooding is a Scientia Professor in the School of Chemistry at the University of New South Wales and is currently an National Health and Medical Research Council Leadership Fellow as well as a fellow of the Australian Academy of Science and the Australian Academy of Technology and Engineering and was previously an Australian Research Council Australian Laureate Fellow. He is the inaugural editor-in-chief of the journal ACS Sensors. He is the former founding co-director of the Australian Centre for NanoMedicine and the co-director of the New South Wales Smart Sensing Network. 

He leads a research team of over 40 researchers interested in surface modification and nanotechnology for biosensors for medical applications, electrocatalysis and 3D cell printing. He has extensive collaborative experience with start-up companies and has been involved in the commercialisation of glucose biosensors, 3D bioprinters and an in vivo sensing platform for therapeutic drug monitoring.

Professor Zaiping Guo is an Australian Laureate Fellow at School of Chemical Engineering, The University of Adelaide. She received her PhD from University of Wollongong in 2003 and was elected to Fellow of the Australian Academy of Science and the Australian Academy of Technological Sciences and Engineering in 2023. Her research focuses on the design and application of electrode materials and electrolyte for energy storage and conversion, including rechargeable batteries, hydrogen storage, and fuel cells. Her research achievements have been recognized through numerous awards, including an ARC Queen Elizabeth II Fellowship in 2010, an ARC Future Professorial Fellowship in 2015, an ARC Laureate Fellowship (2021), and the Clarivate Analytics Highly Cited Researcher Award in 2018, 2019, 2020, 2021, 2022 and 2023. Furthermore, in 2020, she was honored with the NSW Premier's Prizes for Science & Engineering, specifically for her outstanding achievements in Engineering or Information and Communications Technology

Dr. Charles Henry is a Professor of Chemistry, Chemical & Biological Engineering, and Biomedical Engineering at Colorado State University and an adjunct Professor in the Metallurgy and Materials Science Research Institute at Chulalongkorn University in Thailand. He received his Ph.D. in Analytical Chemistry under the supervision of Dr. Ingrid Fritsch at the University of Arkansas and was an NIH postdoctoral fellow at the University of Kansas under the supervision of Dr. Susan Lunte. His research interests lie broadly in the areas of microfluidics, electrochemistry, and sensors with application to questions in bioanalytical and environmental chemistry. Dr. Henry was the recipient of the inaugural ACS Measurement Science award in 2019 and was named Professor Laureate by the College of Natural Sciences at CSU. Dr. Henry has helped found multiple startup companies and is an associate editor for Analytica Chimica Acta.

Dawei Jiang, received his Ph.D. in Inorganic Chemistry from Shanghai Institute of Applied Physics, Chinese Academy of Sciences in 2015. After five years of postdoctoral training in Prof. Weibo Cai’s lab at the University of Wisconsin - Madison, he joined Wuhan Union Hospital as a full professor in 2020 and now serves as the deputy director of the Department of Nuclear Medicine. 

His research interests focus on the design and development of DNA and antibody-based PET tracers for medical imaging and disease treatment. He has authored >130 academic papers in top academic journals including Nature Biomedical Engineering, Nature Communications, JNM, and EJNMMI. He was awarded "2019 Ones to Watch" and "Michael J. Welch Postdoctoral Award" by the Society of Nuclear Medicine and Molecular Imaging. He is currently the Editor-in-Chief of Am. J. Nucl. Med. Mol. Imaging and serves in the editorial boards of EJNMMI, Journal of Nanobiotechnology, and Molecular Pharmaceutics.

Dr Minkyung Kang completed her PhD at the University of Warwick (UK) in 2018. She worked as a research fellow at Imperial College London (2017-2018) and the University of Warwick (2018-2020; Leverhulme Early Career Fellowship) before joining Deakin University in 2020. In 2023, she has joined the School of Chemistry at the University of Sydney as an ARC DECRA fellow/lecturer. Her research focus centres around electrochemistry, and she is currently working on developing a unique electrochemical imaging technology to aid in the rational design of efficient energy conversion/storage materials.

Professor Doug MacFarlane is a Sir John Monash Distinguished Professor at Monash University. He was a BSc(Hons) graduate from Victoria University of Wellington and then undertook his PhD at Purdue University before taking up a position at Monash. His interests include electrochemistry of ionic liquids and applications in renewable energy, including generation of hydrogen and ammonia. He has published more than 800 papers, cited > 80,000 times (h-index 134). He has been a Clarivate “highly cited author” since 2019. He was elected to the Australian Academy of Science in 2007 and the Australian Academy of Technological Sciences and Engineering in 2009. His group has recently spun-out a company, Jupiter Ionics P/L to scale up their ammonia production technology and was awarded the Royal Society of Chemistry’s 2023 Horizon Prize.

Jenny Malmström is an Associate Professor at the Department of Chemical and Materials Engineering at the University of Auckland, a PI of the MacDiarmid Institute for Advanced Materials and Nanotechnology and a co-director of the centre of Innovative Materials for Health. She received her MSc degree in Bioengineering from Chalmers and a Ph.D. in Nanoscience from iNANO at the University of Århus. Her research group focusses on creating functional biointerfaces to understand and control biological systems and on using materials and inspiration from nature to produce functional materials. For example, the group works to understand non-classical properties of biological molecules, such as piezoelectricity, and uses self-assembly of magnetic molecules to create advanced materials.